CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文
BREAST CANCER RESEARCH, 2017, 卷号: 19
作者:  Toi, Masakazu;  Shao, Zhimin;  Hurvitz, Sara;  Tseng, Ling-Ming;  Zhang, Qingyuan
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/11
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文
2017, 卷号: 19, 期号: 1, 页码: 47
作者:  Toi Masakazu;  Shao Zhimin;  Hurvitz Sara;  Tseng Ling-Ming;  Zhang Qingyuan
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:12/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace